ArticleAlzheimer's research & therapy2019

Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice.

Sofía Fernández de Retana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.